查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827700

2025年全球分叉病變市場報告

Bifurcation Lesions Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，分叉病變市場規模強勁成長，從2024年的26.3億美元增加至2025年的28.4億美元，複合年成長率達7.8%。這段時期的成長歸因於冠狀動脈疾病盛行率的上升、老年人口的成長、醫療支出的增加、經濟成長。

預計未來幾年分叉病變市場規模將強勁成長，到2029年將達到40.1億美元，複合年成長率為9.1%。預測期內的成長歸因於微創手術需求的不斷成長、醫療基礎設施和設施的擴建、心血管疾病盛行率的上升以及政府醫療政策的訂定。預測期內的主要趨勢包括以患者為中心的治療方法、生物可吸收支架、人工智慧和機器學習的整合以及跨學科合作。

冠狀動脈分叉病變是指鄰近或涉及重要側支起始處的動脈發生狹窄，而該側支原本應予以保留。當斑塊積聚導致動脈狹窄，阻礙血液流向心臟時，就會發生這種情況。

分叉病灶主要分為單支架入路和雙支架入路。在單支架分叉病變手術中，如果根據臨床症狀、血管造影術結果或其他相關因素認為需要干預，則在側支中暫時放置支架。在這種方法中，首先在主支中置入支架。分叉角由主支和側支的內角決定。這類分叉病變常見於冠狀動脈和周邊血管。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 全新報告系列的一部分，該系列提供分叉病變市場統計數據，例如全球市場規模、區域佔有率、競爭對手的分叉病變市場佔有率、詳細的分叉病變細分市場、市場趨勢和機遇，以及您在分叉病變行業取得成功所需的數據。本分叉病變市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切全面觀點。

未來五年的預測成長率為9.1%，較我們先前對該市場的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。這種影響透過對義大利和荷蘭的專用導管導引線和藥物塗層球囊徵收關稅直接影響美國，可能導致複雜冠狀動脈手術的供不應求。

預計分叉病市場的成長將受到老年人口不斷成長的推動。 60 歲及以上的人更容易患心臟病、中風、心臟疾病和心臟衰竭等心臟相關疾病。分叉病在治療此類情況下的血栓和促進心臟充足的血液流動方面起著關鍵作用。根據世界衛生組織 (WHO) 的報告，到 2030 年，全球六分之一的人將年滿 60 歲或以上，而到 2050 年，80 歲及以上人口的數量預計將比現在增加 4.26 億。不斷成長的老年人口預計將成為分叉病市場的主要驅動力。

預計未來幾年，不斷成長的醫療支出將推動分叉病變市場的成長。醫療基礎設施涵蓋與醫療保健、預防措施、公共衛生活動、復健、社區健康活動、健康監測等相關的所有費用。不斷成長的醫療支出使醫療機構能夠投資尖端設備和技術，例如先進的介入性心臟病學設備，以治療分叉病變。例如，2023年11月，總部位於加拿大的非營利組織加拿大衛生資訊研究所預測，繼2022年僅溫和成長1.5%之後，2023年加拿大的醫療保健總支出將增加2.8%。因此，不斷成長的醫療支出正在推動分叉病變市場的成長。

推動分叉病變市場發展的關鍵趨勢之一是影像和手術器械的進步。市場主要企業正致力於增強現有的影像和手術器械。例如，臨床階段醫療設備公司 Advanced Bifurcation Systems (ABS) 開發了一種獨特的分叉支架解決方案，該方案採用模組化自對準支架技術。該平台旨在標準化冠狀動脈血管成形術中所有分叉病變的治療，提供單一系統，減少再次手術的需求，並實現高效的分叉支架植入。器械的進步趨勢正在推動分叉病變市場的成長和創新。

分叉病變市場的主要企業正在積極開發創新產品，例如藥物釋放型冠狀動脈支架系統，以擴大基本客群、增加銷售並推動收益成長。藥物釋放型冠狀動脈支架系統是用於介入性心臟病學治療冠狀動脈疾病的專用醫療設備。 2023 年 8 月，愛爾蘭醫療設備製造商Medtronic力公司推出了 Onyx Frontier藥物釋放型支架 (DES)，用於使用臨時支架治療非左主幹分叉病變。該產品具有幾項設計改進，包括雙層球囊、減少的橫截面和提高的導管靈活性。與上一代 Resolute Onyx DES 相比，這些改進將輸送能力提高了 16%，同時保持了相同的徑向強度。 Onyx Frontier 有多種尺寸可供選擇，從 2.0 毫米到 5.0 毫米，具有專門的尺寸來滿足患者對治療非常大的血管（包括左主幹）的需求。該產品繼承了Resolute Onyx的臨床數據和適應症，包括核准用於治療分叉核准、左主幹經皮冠狀動脈介入治療（PCI），以及建議用於高出血風險患者的一個月雙重抗血小板治療（DAPT）。

2024年6月，美國醫療科技公司波士頓科學公司（Boston Scientific Corporation）以11.8億美元收購了絲路醫療公司（Silk Road Medical）。此次收購旨在增強波士頓科學公司在血管市場的產品陣容和競爭地位，利用創新技術改善患者治療效果並擴大新市場。絲路醫療是一家專注於開發頸動脈手術創新解決方案的醫療設備製造商。

分叉病變市場的主要公司包括波士頓科學公司、泰爾茂醫療公司、Spectranetics 公司、Medtronic力公司、康德樂公司、康德樂公司、雅培實驗室、Biosensors 國際Group Limited、B. Braun Terumo Corporation AG、Cook Medical LLC、Cordis 公司、Endologics 公司、W.L. Gore & AssociatesC、Inspire & AssociatesC. KG、Cardionovum GmbH、Elixir Medical 公司、Medinol 有限公司、Meril Life Sciences Pvt. 有限公司、Opto Circuits (India) 有限公司、QualiMed Innovative Medizinprodukte GmbH 和 Sahajanand Medical Technologies Pvt。 Ltd.、Svelte Medical Systems Inc.、Translumina GmbH、Vascular Concepts Limited、Vascular Solutions Inc.、Veryan Medical Ltd.、X-Cell Medical Inc.、Zorion Medical Inc.、Amaranth Medical Inc.、Cardiomind Inc.、Cardiva Medical Inc.

2024年，北美是分叉病變市場最大的地區。預計亞太地區將成為預測期內成長最快的地區。分叉病變市場報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

分叉病變市場報告涵蓋的國家有澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國和美國。

分叉病變市場包括近端主支 (MB)、遠端主支 (MB) 和側支 (SB) 的收益。市場價值包括服務供應商銷售或包含在服務產品中的相關商品的價值。僅包括營業單位之間交易或銷售給最終消費者的商品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球分歧：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球分岔病變市場：成長率分析
  • 全球分叉病變市場表現：規模與成長，2019-2024
  • 全球分叉病變市場預測：2024-2029年及2034年規模與成長
  • 全球分叉病變：總可尋址市場（TAM）

第6章 市場細分

  • 全球分叉病變市場：依類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 一個支架
  • 2個支架
  • 全球分叉病變市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 冠狀動脈血管
  • 周邊血管
  • 全球分叉病變市場：按單支架類型細分、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 單支架置入
  • 球囊擴張型支架
  • 自動擴張型支架
  • 全球分叉病變市場：細分 2：支架（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 粉碎技術
  • T形或Y形支架
  • 側支支架置入術

第7章 區域和國家分析

  • 全球分叉病變市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球分叉病變市場：依國家、表現及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 分叉病變市場：競爭格局
  • 分叉病變市場：公司簡介
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Terumo Medical Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Spectranetics Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Cardinal Health Company
  • Abbott Laboratories
  • Biosensors International Group Ltd.
  • B. Braun Melsungen AG
  • Cook Medical LLC
  • Cordis Corporation
  • Endologix Inc.
  • WL Gore & Associates Inc.
  • InspireMD Inc.
  • MicroPort Scientific Corporation
  • OrbusNeich Medical Company Limited
  • Biotronik SE & Co. KG
  • Cardionovum GmbH
  • Elixir Medical Corporation
  • Medinol Ltd.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年分叉病變市場：提供新機會的國家
  • 2029年分叉病變市場：細分領域帶來新機會
  • 2029年分叉病變市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r21137u

Bifurcation lesions in the context of coronary arteries refer to constrictions that occur adjacent to or involve the origin of a critical side branch that one aims to preserve. This situation arises when there is an accumulation of plaque deposits, causing the artery to become too narrow, thereby hindering adequate blood flow to the heart.

The main categorizations of bifurcation lesions are one-stent and two-stent approaches. In a one-stent bifurcation lesion procedure, the side branch is provisionally stented if intervention is deemed necessary based on clinical complaints, angiographic results, or other relevant factors. In this approach, the main branch is stented first. The bifurcation angle is determined by the internal angle between the main and side branches. These types of bifurcation lesions are encountered in both coronary and peripheral vascular contexts.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The bifurcation lesions market research report is one of a series of new reports from The Business Research Company that provides bifurcation lesions market statistics, including bifurcation lesions industry global market size, regional shares, competitors with a bifurcation lesions market share, detailed bifurcation lesions market segments, market trends and opportunities, and any further data you may need to thrive in the bifurcation lesions industry. This bifurcation lesions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bifurcation lesions market size has grown strongly in recent years. It will grow from $2.63 billion in 2024 to $2.84 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to rise in prevalence of coronary artery diseases, rise in geriatric population, rise in healthcare expenditure, economic growth.

The bifurcation lesions market size is expected to see strong growth in the next few years. It will grow to $4.01 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for minimally invasive surgeries, expansion of healthcare infrastructure and facilities, increasing prevalence of cardiovascular diseases, government healthcare policies. Major trends in the forecast period include patient-centric approaches, bioresorbable stents, integration of ai and machine learning, cross-specialty collaboration.

The forecast of 9.1% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on specialized guidewires and drug-coated balloons from Italy and the Netherlands, potentially causing supply shortages for complex coronary procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the bifurcation lesions market is expected to be driven by the increasing geriatric population. Individuals aged 60 and above are more susceptible to heart-related issues such as heart attacks, strokes, coronary heart disease, and heart failure. Bifurcation lesions play a crucial role in treating blood clots and facilitating adequate blood flow to the heart in such cases. A report by the World Health Organization (WHO) projected that by 2030, one in six people globally would be 60 or older, and by 2050, the number of individuals aged 80 and above would increase by 426 million compared to the current population. The rise in the geriatric population is anticipated to be a significant driver for the bifurcation lesions market.

The rising healthcare expenditure is expected to drive the growth of the bifurcation lesions market in the future. Healthcare infrastructure encompasses all expenses related to medical care, preventive measures, public health initiatives, rehabilitation, community health activities, and health research. Increased healthcare spending enables healthcare facilities to invest in cutting-edge equipment and technologies, including advanced interventional cardiology devices for treating bifurcation lesions. For example, in November 2023, the Canadian Institute for Health Information, a non-profit organization based in Canada, projected that total health spending in Canada would increase by 2.8% in 2023, following a modest growth of only 1.5% in 2022. Consequently, the rising healthcare expenditure is propelling the growth of the bifurcation lesions market.

A key trend gaining popularity in the bifurcation lesions market is the advancement in devices used in imaging and procedures. Leading companies in the market are focusing on enhancing existing devices used in imaging and procedures. For example, Advanced Bifurcation Systems (ABS), a clinical-stage medical device firm, has developed a unique bifurcation stenting solution featuring modular self-aligning stent technology. This platform aims to standardize the treatment of all bifurcation lesions in coronary angioplasties, providing a single system that reduces the need for repeat procedures and enables effective bifurcation stenting treatment. The trend towards device advancement is contributing to the growth and innovation in the bifurcation lesions market.

Leading companies in the bifurcation lesions market are actively developing innovative products such as drug-eluting coronary stent systems to expand their customer base, increase sales, and drive revenue growth. A drug-eluting coronary stent system is a specialized medical device used in interventional cardiology for the treatment of coronary artery disease. In August 2023, Medtronic PLC, an Ireland-based medical device company, introduced the Onyx Frontier drug-eluting stent (DES) to address non-left main bifurcation lesions using the provisional stenting technique. This product incorporates several design enhancements, including a dual-layer balloon, reduced crossing profile, and enhanced catheter flexibility. The improvements result in a 16% enhancement in deliverability compared to the prior-generation Resolute Onyx DES, maintaining the same level of radial strength. Onyx Frontier offers an extensive range of sizes, accommodating patient needs with diameters ranging from 2.0mm to 5.0mm, with specific sizing for the treatment of extra-large vessels, including those in the left main. The product inherits clinical data and indications from Resolute Onyx, including approval for treating bifurcation lesions, left main percutaneous coronary intervention (PCI), and a recommended one-month duration of dual antiplatelet therapy (DAPT) for high bleeding risk patients.

In June 2024, Boston Scientific Corporation, a medical technology company based in the US, acquired Silk Road Medical, Inc. for $1.18 billion. The acquisition aims to enhance Boston Scientific's product offerings and competitive position in the vascular market by leveraging innovative technologies to improve patient outcomes and expand into new markets. Silk Road Medical, Inc. is a medical device firm that focuses on developing innovative solutions for carotid artery procedures.

Major companies operating in the bifurcation lesions market include Boston Scientific Corporation, Terumo Medical Corporation, Spectranetics Corporation, Medtronic plc, Cardinal Health Inc., Cardinal Health Company, Abbott Laboratories, Biosensors International Group Ltd., B. Braun Melsungen AG, Cook Medical LLC, Cordis Corporation, Endologix Inc., W. L. Gore & Associates Inc., InspireMD Inc., MicroPort Scientific Corporation, OrbusNeich Medical Company Limited, Biotronik SE & Co. KG, Cardionovum GmbH, Elixir Medical Corporation, Medinol Ltd., Meril Life Sciences Pvt. Ltd., Opto Circuits (India) Ltd., QualiMed Innovative Medizinprodukte GmbH, Sahajanand Medical Technologies Pvt. Ltd., Svelte Medical Systems Inc., Translumina GmbH, Vascular Concepts Limited, Vascular Solutions Inc., Veryan Medical Ltd., X-Cell Medical Inc., Zorion Medical Inc., Amaranth Medical Inc., Cardiomind Inc., Cardiva Medical Inc.

North America was the largest region in the bifurcation lesions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bifurcation lesions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the bifurcation lesions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The bifurcation lesions market includes revenues earned by proximal main branch (MB), distal MB and side branch (SB). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bifurcation Lesions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bifurcation lesions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bifurcation lesions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bifurcation lesions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Types: One-Stent; Two-Stent
  • 2) By Application: Coronary Vascular; Peripheral Vascular
  • Subsegments:
  • 1) By One-Stent: Single-Stent Deployment; Balloon-Expandable Stents; Self-Expanding Stents
  • 2) By Two-Stent: Crush Technique; T- or Y-Configuration Stenting; Side Branch Stenting Techniques
  • Companies Mentioned: Boston Scientific Corporation; Terumo Medical Corporation; Spectranetics Corporation; Medtronic plc; Cardinal Health Inc.; Cardinal Health Company; Abbott Laboratories; Biosensors International Group Ltd.; B. Braun Melsungen AG; Cook Medical LLC; Cordis Corporation; Endologix Inc.; W. L. Gore & Associates Inc.; InspireMD Inc.; MicroPort Scientific Corporation; OrbusNeich Medical Company Limited; Biotronik SE & Co. KG; Cardionovum GmbH; Elixir Medical Corporation; Medinol Ltd.; Meril Life Sciences Pvt. Ltd.; Opto Circuits (India) Ltd.; QualiMed Innovative Medizinprodukte GmbH; Sahajanand Medical Technologies Pvt. Ltd.; Svelte Medical Systems Inc.; Translumina GmbH; Vascular Concepts Limited; Vascular Solutions Inc.; Veryan Medical Ltd.; X-Cell Medical Inc.; Zorion Medical Inc.; Amaranth Medical Inc.; Cardiomind Inc.; Cardiva Medical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bifurcation Lesions Market Characteristics

3. Bifurcation Lesions Market Trends And Strategies

4. Bifurcation Lesions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Bifurcation Lesions Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Bifurcation Lesions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Bifurcation Lesions Market Growth Rate Analysis
  • 5.4. Global Bifurcation Lesions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Bifurcation Lesions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Bifurcation Lesions Total Addressable Market (TAM)

6. Bifurcation Lesions Market Segmentation

  • 6.1. Global Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • One-Stent
  • Two-Stent
  • 6.2. Global Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Coronary Vascular
  • Peripheral Vascular
  • 6.3. Global Bifurcation Lesions Market, Sub-Segmentation Of One-Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Stent Deployment
  • Balloon-Expandable Stents
  • Self-Expanding Stents
  • 6.4. Global Bifurcation Lesions Market, Sub-Segmentation Of Two-Stent, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Crush Technique
  • T- or Y-Configuration Stenting
  • Side Branch Stenting Techniques

7. Bifurcation Lesions Market Regional And Country Analysis

  • 7.1. Global Bifurcation Lesions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Bifurcation Lesions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bifurcation Lesions Market

  • 8.1. Asia-Pacific Bifurcation Lesions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bifurcation Lesions Market

  • 9.1. China Bifurcation Lesions Market Overview
  • 9.2. China Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bifurcation Lesions Market

  • 10.1. India Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bifurcation Lesions Market

  • 11.1. Japan Bifurcation Lesions Market Overview
  • 11.2. Japan Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bifurcation Lesions Market

  • 12.1. Australia Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bifurcation Lesions Market

  • 13.1. Indonesia Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bifurcation Lesions Market

  • 14.1. South Korea Bifurcation Lesions Market Overview
  • 14.2. South Korea Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bifurcation Lesions Market

  • 15.1. Western Europe Bifurcation Lesions Market Overview
  • 15.2. Western Europe Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bifurcation Lesions Market

  • 16.1. UK Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bifurcation Lesions Market

  • 17.1. Germany Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bifurcation Lesions Market

  • 18.1. France Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bifurcation Lesions Market

  • 19.1. Italy Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bifurcation Lesions Market

  • 20.1. Spain Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bifurcation Lesions Market

  • 21.1. Eastern Europe Bifurcation Lesions Market Overview
  • 21.2. Eastern Europe Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bifurcation Lesions Market

  • 22.1. Russia Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bifurcation Lesions Market

  • 23.1. North America Bifurcation Lesions Market Overview
  • 23.2. North America Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bifurcation Lesions Market

  • 24.1. USA Bifurcation Lesions Market Overview
  • 24.2. USA Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bifurcation Lesions Market

  • 25.1. Canada Bifurcation Lesions Market Overview
  • 25.2. Canada Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bifurcation Lesions Market

  • 26.1. South America Bifurcation Lesions Market Overview
  • 26.2. South America Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bifurcation Lesions Market

  • 27.1. Brazil Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bifurcation Lesions Market

  • 28.1. Middle East Bifurcation Lesions Market Overview
  • 28.2. Middle East Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bifurcation Lesions Market

  • 29.1. Africa Bifurcation Lesions Market Overview
  • 29.2. Africa Bifurcation Lesions Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Bifurcation Lesions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bifurcation Lesions Market Competitive Landscape And Company Profiles

  • 30.1. Bifurcation Lesions Market Competitive Landscape
  • 30.2. Bifurcation Lesions Market Company Profiles
    • 30.2.1. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Terumo Medical Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Spectranetics Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Bifurcation Lesions Market Other Major And Innovative Companies

  • 31.1. Cardinal Health Company
  • 31.2. Abbott Laboratories
  • 31.3. Biosensors International Group Ltd.
  • 31.4. B. Braun Melsungen AG
  • 31.5. Cook Medical LLC
  • 31.6. Cordis Corporation
  • 31.7. Endologix Inc.
  • 31.8. W. L. Gore & Associates Inc.
  • 31.9. InspireMD Inc.
  • 31.10. MicroPort Scientific Corporation
  • 31.11. OrbusNeich Medical Company Limited
  • 31.12. Biotronik SE & Co. KG
  • 31.13. Cardionovum GmbH
  • 31.14. Elixir Medical Corporation
  • 31.15. Medinol Ltd.

32. Global Bifurcation Lesions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bifurcation Lesions Market

34. Recent Developments In The Bifurcation Lesions Market

35. Bifurcation Lesions Market High Potential Countries, Segments and Strategies

  • 35.1 Bifurcation Lesions Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Bifurcation Lesions Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Bifurcation Lesions Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer